EUVIMEDEUVIMED entdecken
Crossref

Efficacy of Photodynamic Diagnosis Is Confined to the Low‐Risk Subgroup of Intermediate‐Risk Non‐Muscle‐Invasive Bladder Cancer: A Propensity Score Matched Analysis

Yohei Abe iD, Rikiya Taoka iD, Asuka Kaji, Satoshi Harada, Kengo Fujiwara, Kana Kohashiguchi, Hirohito Naito iD, Yoichiro Tohi iD, Takuma Kato iD, Homare Okazoe, Nobufumi Ueda, Mikio Sugimoto iD

International Journal of Urology · 2026

DOI: 10.1111/iju.70365 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Urology, 2026. Verfasst von Yohei Abe und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Faculty of Medicine, Kagawa University, Kagawa, Japan. Hauptthemen laut MEDLINE: Non-Muscle Invasive Bladder Neoplasms, Neoplasm Recurrence, Local, Urinary Bladder Neoplasms. Die Arbeit nennt 30 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

Intermediate‐risk (IR) non‐muscle‐invasive bladder cancer (NMIBC) is a heterogeneous disease. In this study, we aimed to evaluate the efficacy of photodynamic diagnosis (PDD)‐assisted transurethral resection of the bladder (TURBT) using the recently validated International Bladder Cancer Group (IBCG) risk stratification model for IR‐NMIBC.

Methods

We conducted a single‐center retrospective analysis of 193 patients with IR‐NMIBC who underwent either PDD‐assisted with oral 5‐aminolevulinic acid ( n = 69) or white‐light (WL) TURBT ( n = 126) between 2009 and 2023. We performed 1:1 propensity score matching (PSM) to balance baseline characteristics. Recurrence‐free survival (RFS) was compared between the groups using the Kaplan–Meier method with subgroup analyses based on IBCG risk strata (IR‐low, IR‐intermediate/high).

Results

After PSM, 69 patients with well‐balanced characteristics remained in each group. PDD was associated with a significantly improved RFS compared with WL‐TURBT in the overall cohort ( p = 0.016). Using subgroup analysis, this benefit was most pronounced in the IR‐low risk group ( p = 0.025), whereas no significant difference was found in the IR‐intermediate/high‐risk group ( p = 0.14). Regarding multivariate analysis, PDD was an independent predictor of improved RFS in both the entire IR cohort (hazard ratio [HR]: 0.421, p = 0.009) and IR‐low subgroup (HR: 0.361, p = 0.047).

Conclusions

PDD‐assisted TURBT significantly improved the recurrence outcomes in patients with IR‐NMIBC, with the greatest benefit observed in the IR‐low risk subgroup. These findings support a stratified approach in which PDD is a cornerstone of management of IR‐low patients, while highlighting the need for further research to optimize treatment strategies for IR‐intermediate/high patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Non-Muscle Invasive Bladder NeoplasmsNeoplasm Recurrence, LocalUrinary Bladder NeoplasmsHumansPropensity ScoreTransurethral Resection of BladderRetrospective StudiesFemaleAminolevulinic AcidMaleAgedRisk AssessmentPhotosensitizing AgentsMiddle AgedAged, 80 and overDisease-Free SurvivalUrinary BladderKaplan-Meier Estimate

Stichwörter der Autor:innen

aminolevulinic aciddisease progressionnon‐muscle‐invasive bladder neoplasmsrisk assessmenturinary bladder

Substanzen

Aminolevulinic AcidPhotosensitizing Agents

Autor:innen und Institutionen

  • Department of Urology, Faculty of Medicine, Kagawa University, Kagawa, Japan.

ORCID-Profile: Yohei Abe, Rikiya Taoka, Hirohito Naito, Yoichiro Tohi, Takuma Kato, Mikio Sugimoto

Zitieren

APA

Abe, Y., Taoka, R., Kaji, A., Harada, S., Fujiwara, K., Kohashiguchi, K., Naito, H., Tohi, Y., Kato, T., Okazoe, H., Ueda, N., & Sugimoto, M. (2026). Efficacy of Photodynamic Diagnosis Is Confined to the Low‐Risk Subgroup of Intermediate‐Risk Non‐Muscle‐Invasive Bladder Cancer: A Propensity Score Matched Analysis. International Journal of Urology. https://doi.org/10.1111/iju.70365

Vancouver

Abe Y, Taoka R, Kaji A, Harada S, Fujiwara K, Kohashiguchi K, et al. Efficacy of Photodynamic Diagnosis Is Confined to the Low‐Risk Subgroup of Intermediate‐Risk Non‐Muscle‐Invasive Bladder Cancer: A Propensity Score Matched Analysis. International Journal of Urology. 2026. doi:10.1111/iju.70365

BibTeX
@article{Abe2026,
  author = {Abe, Yohei and Taoka, Rikiya and Kaji, Asuka and Harada, Satoshi and Fujiwara, Kengo and Kohashiguchi, Kana and Naito, Hirohito and Tohi, Yoichiro and Kato, Takuma and Okazoe, Homare and Ueda, Nobufumi and Sugimoto, Mikio},
  title = {Efficacy of Photodynamic Diagnosis Is Confined to the Low‐Risk Subgroup of Intermediate‐Risk Non‐Muscle‐Invasive Bladder Cancer: A Propensity Score Matched Analysis},
  journal = {International Journal of Urology},
  year = {2026},
  doi = {10.1111/iju.70365}
}
Kostenlos starten →